Department of Pharmacology, Ernst Moritz Arndt University, Felix-Haussdorf-Str.3, 17487 Greifswald, Germany.
Eur J Pharm Sci. 2012 Nov 20;47(4):774-80. doi: 10.1016/j.ejps.2012.08.017. Epub 2012 Sep 8.
Previously, the steroid hormone progesterone has been demonstrated to stimulate OATP2B1-mediated transport of estrone-3-sulphate (E(1)S), dehydroepiandrosterone sulphate (DHEAS) and pregnenolone sulphate (PS), which may influence the uptake of precursor molecules for steroid hormone synthesis. However, it is unclear whether OATP2B1 drug substrates like atorvastatin or glibenclamide are also affected by this phenomenon. In addition, it has not been studied so far if this stimulatory effect is specific for OATP2B1. To address these questions, we examined the influence of progesterone on OATP2B1-mediated atorvastatin and glibenclamide uptake and studied the impact of steroid hormones on the transport activity of OATP1A2, OATP1B1 and OATP1B3. Comparison of the substrate spectrum of the investigated OATPs revealed that DHEAS and atorvastatin are substrates of all transporters, while E(1)S was only significantly transported by OATP1A2, OATP2B1 and OATP1B1. Glibenclamide uptake was limited to OATP1A2, OATP1B1 and OATP2'B1. Subsequent interaction studies indicated that progesterone only increases OATP2B1-mediated E(1)S and DHEAS transport, whereas uptake of BSP, atorvastatin and glibenclamide was either inhibited or not affected. Moreover, the steroid hormone effect was specific for OATP2B1; neither OATP1B1, OATP1B3 nor OATP1A2 function was stimulated in the presence of progesterone. Similar to progesterone, the glucocorticoide dexamethasone stimulated OATP2B1-mediated transport of E(1)S and DHEAS (EC(50) for E(1)S: 10.2 ± 5.6 μM and 17.9 ± 15.4 μM for DHEAS). In conclusion, our data demonstrate that among the tested compounds the stimulatory effect of progesterone is specific for OATP2B1 and restricted to sulphated steroids like E(1)S and DHEAS while the OATP-mediated drug transport is not enhanced.
先前,甾体激素孕酮已被证实可刺激 OATP2B1 介导的雌酮-3-硫酸盐(E(1)S)、脱氢表雄酮硫酸盐(DHEAS)和孕烯醇酮硫酸盐(PS)的转运,这可能会影响甾体激素合成的前体分子的摄取。然而,目前尚不清楚 OATP2B1 药物底物(如阿托伐他汀或格列本脲)是否也受到这种现象的影响。此外,迄今为止,尚未研究这种刺激作用是否对 OATP2B1 具有特异性。为了解决这些问题,我们研究了孕酮对 OATP2B1 介导的阿托伐他汀和格列本脲摄取的影响,并研究了甾体激素对 OATP1A2、OATP1B1 和 OATP1B3 转运活性的影响。对所研究的 OATP 底物谱的比较表明,DHEAS 和阿托伐他汀是所有转运体的底物,而 E(1)S 仅被 OATP1A2、OATP2B1 和 OATP1B1 显著转运。格列本脲摄取仅限于 OATP1A2、OATP1B1 和 OATP2'B1。随后的相互作用研究表明,孕酮仅增加 OATP2B1 介导的 E(1)S 和 DHEAS 转运,而 BSP、阿托伐他汀和格列本脲的摄取受到抑制或不受影响。此外,甾体激素的作用对 OATP2B1 具有特异性;在孕酮存在的情况下,OATP1B1、OATP1B3 或 OATP1A2 功能均未受到刺激。与孕酮类似,糖皮质激素地塞米松刺激 OATP2B1 介导的 E(1)S 和 DHEAS 转运(E(1)S 的 EC(50)为 10.2 ± 5.6 μM,DHEAS 的 EC(50)为 17.9 ± 15.4 μM)。总之,我们的数据表明,在所测试的化合物中,孕酮的刺激作用对 OATP2B1 具有特异性,仅限于 E(1)S 和 DHEAS 等硫酸化甾体,而 OATP 介导的药物转运并未增强。